nivolumab–cabozantinib boosts advanced rcc outcomes | andrea apolo
Published 4 years ago • 546 plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
3:31
cabozantinib–nivolumab and ipilimumab combinations show potential for gu cancers | andrea apolo
-
5:58
checkmate 9er update confirms benefits of nivolumab–cabozantinib in rcc | cristina suárez
-
0:55
dr. apolo on the combination of cabozantinib plus nivolumab in urothelial carcinoma
-
2:09
dr. apolo on cabozantinib plus nivolumab and ipilimumab in urothelial carcinoma
-
3:49
cabozantinib benefit for metastatic papillary rcc demonstrated | sumanta pal
-
1:35
checkmate-9er shows efficacy of nivolumab/cabozantinib combo in rcc
-
0:57
exploring cabozantinib with nivolumab and ipilimumab in urothelial carcinoma
-
2:43
cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced rcc
-
34:59
nuclear medicine imaging in brain neoplasm
-
25:28
systemic treatment of metastatic renal cell cancer: what is state of the art in 2020? - l. albiges
-
5:55
step-by-step guide to using nereus lentihero
-
1:13
dr. apolo on the safety of nivolumab plus cabozantinib in urothelial carcinoma
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
3:53
cabozantinib in combination with immunotherapy for advanced renal cell carcinoma
-
3:16
cabo-nivo or cabo-nivo-ipi for metastatic genitourinary tumors
-
0:56
dr. apolo on immunotherapy combinations with cabozantinib in genitourinary tumors
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
1:56
checkmate 9er: arcc patients on nivolumab plus cabozantinib achieved deeper responses vs sunitinib
-
2:05
esmo 2020 highlights on nivolumab cabozantinib as 1st line therapy for arcc: the checkmate 9er study
-
4:16
durvalumab and oleclumab boost for sbrt plus chemo in er /her2- breast cancer